Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
株式のランク #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
株価
$1.34
最終同期: 2024-02-14
時価総額
$48.96M
変化(1日)
-12.94%
変化(1年)
0.00%
SE
取引 Promore Pharma AB (publ) (PROMO)

カテゴリー

Promore Pharma AB (publ)(PROMO)の配当利回りの履歴
Promore Pharma AB (publ)(銘柄コード: PROMO)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Promore Pharma AB (publ)(PROMO)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)